STAT Plus: Merck’s Roger Perlmutter joins board of AI drug discovery startup Insitro
MERCK
Roger Perlmutter, the head of R&D at Merck, is joining the board of Insitro, a firm using artificial intelligence to discover drugs.
Suscribirse a:
Enviar comentarios (Atom)
.png)
No hay comentarios:
Publicar un comentario